Sun Pharma, Alembic recall products in US market
SECTIONS
Last Updated: Apr 18, 2021, 11:47 AM IST
Share
Synopsis
According to industry estimates, the US generic drug market was estimated to be around $115.2 billion in 2019.
According to the US regulator, a class III recall is initiated in a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences .
Related
NSE
Explore Now
NEW DELHI: Leading drug makers Sun Pharma and Alembic Pharmaceuticals are recalling different products in the US, the world s largest market for medicines.
As per the latest Enforcement Report by the US Food and Drug Administration (USFDA), US-based unit of Sun Pharma is recalling 91,211 pre-filled syringes of Ganirelix Acetate injection due to failed impurities/degradation specifications .
Parents are Very Worried About the Effects of Severe Acne on their Teenage Children as Reported in a New Survey
- Deep concerns about physical, emotional, and social impact underscore urgency to effectively treat severe acne and mitigate prolonged distress(1)
Findings reflect heightened stress on families as teens cope with isolation and embarrassment; remote schooling eases some worries but exacerbates others
News provided by
Share this article
Share this article
PRINCETON, N.J., April 7, 2021 /PRNewswire/ Sun Pharmaceutical Industries Inc., USA (Sun Pharma), a wholly owned subsidiary of Mumbai-based Sun Pharmaceutical Industries Limited, today released results of a survey that reveals a deep sense of worry among parents in the U.S. about the effects of severe acne on their teenage children. The survey, which was sponsored by Sun Pharma, in collaboration with the American Acne and Rosacea Society (AARS), polled 250 parents of teenagers with severe [nodular or cystic] acne, s
Search jobs 12-Mar-2021 Global Calcineurin Inhibitors Market Present Scenario, Key Vendors, Industry Share, and Growth Forecast up to 2028
DBMR has added a new report titled Global Calcineurin Inhibitors Market with analysis provides the insights which bring marketplace clearly into the focus and thus help organizations make better decisions. The data and the information regarding the industry are taken from consistent sources such as websites, annual reports of the companies, and journals which is then checked and validated by the market experts.
Global Calcineurin Inhibitors Market report has been structured with transparent research studies which makes it of supreme quality. By exactly understanding customer requirement, one or more methods are used to construct this finest market research report. The report provides with CAGR value fluctuation during the forecast period of 2020 – 2027 for the market.
Share this article
Share this article
PRINCETON, N.J., March 9, 2021 /PRNewswire/ Sun Pharmaceutical Industries, Inc. (Sun Pharma), a wholly owned subsidiary of Mumbai-based Sun Pharmaceutical Industries Limited, today announced that the top 10 Medicare Part D plans, which include 91% of eligible U.S. lives, now cover Drizalma Sprinkle™.
Drizalma Sprinkle™ is one of three sprinkle formulation products in Sun Pharma s long-term care (LTC) portfolio, which are prescribed inside and outside of LTC facilities for the 40% of American adults who cannot or will not swallow solid medication forms.
Drizalma Sprinkle™ is the first and only U.S. Food and Drug Administration (FDA) approved sprinkle formulation of delayed-release duloxetine capsules and is indicated to treat major depressive disorder (MDD), generalized anxiety disorder (GAD) in adults and pediatric patients aged 7-17, diabetic peripheral neuropathy pain (DPNP), and chronic musculoskeletal pain in adults. Sun Phar
Search jobs 08-Feb-2021 Global Calcineurin Inhibitors Market to Witness Huge Growth by Worldwide| Global Current Trade Size And Future Prospective
Databridgemarketresearch.com Present “
Global Calcineurin Inhibitors Market Industry Trends and Forecast to 2028” new report to its research database. Due to the potential of SWOT analysis and Porter’s Five Forces analysis in generating market research report, they are preferred by the businesses and hence also used while making this report. To structure such a world-class report, the combination of best industry insight, practical solutions, talent solutions and latest technology have been used. As today’s businesses demand the market research analysis to a great extent before taking any verdict about the products, choosing such market research report is essential for the businesses. DBMR team is committed to present the market research report that is promising and the way in whi